CD69 and neoplasm: BCG treatment elevated the proportion of activated CD69+Granzyme-B+ and reduced exhausted PD-1+ TIM-1+CD8+ tumor-infiltrating lymphocytes in control mice (Figure 7F–I; gating scheme in Supplementary Figure S4).